Translational genomics of ovarian clear cell carcinoma.
Khalique S, Lord CJ, Banerjee S, Natrajan R.
Semin Cancer Biol. 2020 Apr;61:121-131. doi: 10.1016/j.semcancer.2019.10.025. Epub 2019 Nov 4.
PMID:31698086
Precision medicine for ovarian clear cell carcinoma based on gene alterations.
Kuroda T, Kohno T.
Int J Clin Oncol. 2020 Mar;25(3):419-424. doi: 10.1007/s10147-020-01622-z. Epub 2020 Feb 4.
PMID:32020380
Ovarian clear cell carcinoma: open questions on the management and treatment algorithm.
Rosso R, Turinetto M, Borella F, Chopin N, Meeus P, Lainè A, Ray-Coquard I, Le Saux O, Ferraioli D.
Oncologist. 2025 Jan 17;30(1):oyae325. doi: 10.1093/oncolo/oyae325.
PMID:39846983
Ovarian Clear Cell Carcinoma: An Endometriosis-Associated Cancer with Therapeutic Challenges.
Huang RY, Lin JJ.
Cold Spring Harb Perspect Med. 2025 Aug 1;15(8):a041315. doi: 10.1101/cshperspect.a041315.
PMID:39284670
Targeting PDGF signaling of cancer-associated fibroblasts blocks feedback activation of HIF-1alpha and tumor progression of clear cell ovarian cancer.
Mori Y, Okimoto Y, Sakai H, Kanda Y, Ohata H, Shiokawa D, Suzuki M, Yoshida H, Ueda H, Sekizuka T, Tamura R, Yamawaki K, Ishiguro T, Mateos RN, Shiraishi Y, Yatabe Y, Hamada A, Yoshihara K, Enomoto T, Okamoto K.